SHORTCAST: Accurate prediction of vaccine candidates using a novel HLA-peptide-TCR-binding tool: OncopeptVAC™ and their validation by OncoPeptSCRN

During this webcast the speaker will address:

• Challenges in accurate prediction of immunogenic neoantigens
• Benefits of the OncoPeptVAC platform
• Assay for immunogenicity of peptides predicted using OncoPeptVAC using OncoPeptSCRN
• Insights into the discoveries made possible using OncoPeptVAC in combination with OncoPeptSCRN & TCR repertoire assays
• Benefits of TCR repertoire profiling to assay for immunogenicity